drugset / Trial / NCT01588574
Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the Optimal dose for safety and efficacy in the treatment of cervical dystonia.
Timeline
- Start
- 2012-08
- Primary completion
- 2013-10
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | — | — |
| Subject | NivobotulinumtoxinA | Protein / enzyme biologic | — | — |